SCOPUS 정보 검색 플랫폼

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 50, Issue 4, 2007, Pages 245-250

Synthesis of isotopically labelled (3-14C)- and (3,3- 2H2)-5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), a new antifungal agent for the potential treatment of onychomycosis

(8) Baker, Stephen J a Zhang, Yong Kang a Akama, Tsutomu a Wheeler, Conrad a Plattner, Jacob J a Rosser, Richard M b Reid, Ronald P b Nixon, Neil S b

a PFIZER INC (United States)

b GE HEALTHCARE (United Kingdom)

Author keywords

AN2690; Antifungal; Onychomycosis; Oxaborole

Indexed keywords

FUNGI; FUNGICIDES;

AN2690; ANTIFUNGALS; BENZOXABOROLE; DEVELOPMENT PHASIS; IN-VITRO; ISOTOPICALLY LABELED; ONYCHOMYCOSIS; OXABOROLE; PRECLINICAL DEVELOPMENT; VITRO STUDIES;

ANTIFUNGAL AGENTS;

5 FLUORO 1,3 DIHYDRO 1 HYDROXY 2,1 BENZOXABOROLE; AN 2690; ANTIFUNGAL AGENT; CARBON 14; DEUTERIUM; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; ISOTOPE LABELING; ONYCHOMYCOSIS;

EID: 34248662947 PISSN: 03624803 EISSN: 10991344 Source Type: Journal
DOI: 10.1002/jlcr.1290 Document Type: Article

Times cited : (8)

References (13)

1
- 0242404222
- Faergemann J, Baran R. Br J Dermatol 2003; 149(Suppl. 65): 1-4.
- (2003) Br J Dermatol , vol.149 , Issue.SUPPL. 65 , pp. 1-4
- Faergemann, J.¹ Baran, R.²

2
- 0042515008
- Gupta AK, Ryder JE, Baran R. Dermatol Clin 2003; 21: 481-489.
- (2003) Dermatol Clin , vol.21 , pp. 481-489
- Gupta, A.K.¹ Ryder, J.E.² Baran, R.³

3
- 0142196749
- Arrese JE, Pierard GE. Dermatology 2003; 207: 255-260.
- (2003) Dermatology , vol.207 , pp. 255-260
- Arrese, J.E.¹ Pierard, G.E.²

4
- 13944258182
- Baran R, Koukhov. J Euro Acad Dermatol Venereol 2005; 19: 21-29.
- (2005) J Euro Acad Dermatol Venereol , vol.19 , pp. 21-29
- Baran, R.¹ Koukhov²

5
- 0037006909
- Murdan S. Int J Pharmaceutics 2002; 236: 1-26.
- (2002) Int J Pharmaceutics , vol.236 , pp. 1-26
- Murdan, S.¹

6
- 0000440615
- Gupchup GV, Zatz JL. J Cosmet Sci 1999; 50: 363-385.
- (1999) J Cosmet Sci , vol.50 , pp. 363-385
- Gupchup, G.V.¹ Zatz, J.L.²

7
- 1442309064
- Kobayashi Y, Komatsu T, Sumi M, Numajiri S, Miyamoto M, Kobayashi D, Sugibayashi K, Morimoto Y. Euro J Pharm Sci 2004; 21: 471-477.
- (2004) Euro J Pharm Sci , vol.21 , pp. 471-477
- Kobayashi, Y.¹ Komatsu, T.² Sumi, M.³ Numajiri, S.⁴ Miyamoto, M.⁵ Kobayashi, D.⁶ Sugibayashi, K.⁷ Morimoto, Y.⁸

8
- 0032946662
- Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y. J Pharm Pharmacol 1999; 51: 271-278.
- (1999) J Pharm Pharmacol , vol.51 , pp. 271-278
- Kobayashi, Y.¹ Miyamoto, M.² Sugibayashi, K.³ Morimoto, Y.⁴

9
- 33746704496
- Baker SJ, Hui X, Maibach HI. Ann Rep Med Chem 2005; 40: 323-335.
- (2005) Ann Rep Med Chem , vol.40 , pp. 323-335
- Baker, S.J.¹ Hui, X.² Maibach, H.I.³

10
- 33746701345
- Baker SJ, Zhang YK, Akama T, Lau A, Zhou H, Hernandez V, Mao W, Alley MRK, Sanders V, Plattner JJ. J Med Chem 2006; 49: 4447-4450.
- (2006) J Med Chem , vol.49 , pp. 4447-4450
- Baker, S.J.¹ Zhang, Y.K.² Akama, T.³ Lau, A.⁴ Zhou, H.⁵ Hernandez, V.⁶ Mao, W.⁷ Alley, M.R.K.⁸ Sanders, V.⁹ Plattner, J.J.¹⁰

11
- 85166706645
- in press
- Hui X, Baker SJ, Wester RC, Barbadillo S, Cashmore AK, Sanders V, Hold KM, Akama T, Zhang YK, Plattner JJ, Maibach HI. J Pharm Sci, in press.
- J Pharm Sci
- Hui, X.¹ Baker, S.J.² Wester, R.C.³ Barbadillo, S.⁴ Cashmore, A.K.⁵ Sanders, V.⁶ Hold, K.M.⁷ Akama, T.⁸ Zhang, Y.K.⁹ Plattner, J.J.¹⁰ Maibach, H.I.¹¹

12
- 0036141745
- Hui X, Shainhouse Z, Tanojo H, Anigbogu A, Markus GE, Maibach HI, Wester RC. J Pharm Sci 2002; 91: 189-195.
- (2002) J Pharm Sci , vol.91 , pp. 189-195
- Hui, X.¹ Shainhouse, Z.² Tanojo, H.³ Anigbogu, A.⁴ Markus, G.E.⁵ Maibach, H.I.⁶ Wester, R.C.⁷

13
- 12244258225
- Hui X, Chan TCK, Barbadillo S, Lee C, Maibach HI, Wester RC. J Pharm Sci 2003; 92: 142-148.
- (2003) J Pharm Sci , vol.92 , pp. 142-148
- Hui, X.¹ Chan, T.C.K.² Barbadillo, S.³ Lee, C.⁴ Maibach, H.I.⁵ Wester, R.C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.